You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Attention Score in Context
| Title |
Alzheimer's Disease and Cancer: Common Targets.
|
|---|---|
| Published in |
Mini Reviews in Medicinal Chemistry, November 2023
|
| DOI | 10.2174/0113895575263108231031132404 |
| Pubmed ID | |
| Authors |
Xueqing Yang, Jinlian Dai, Chenglong Wu, Zongliang Liu |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 December 2023.
All research outputs
#4,906,611
of 25,658,541 outputs
Outputs from Mini Reviews in Medicinal Chemistry
#118
of 977 outputs
Outputs of similar age
#75,706
of 362,500 outputs
Outputs of similar age from Mini Reviews in Medicinal Chemistry
#1
of 23 outputs
Altmetric has tracked 25,658,541 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 977 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.